Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets
Roxane Laboratories’ Mycophenolate Mofetil 250mg Capsules and 500mg Tablets, are AB rated to CellCept(R) (mycophenolate mofetil) capsules and tablets. Annual sales of Mycophenolate Mofetil are approximately
Full prescribing information for Mycophenolate Mofetil Capsules and Tablets is available on the Roxane Laboratories website at www.Roxane.com or upon request by calling Roxane Laboratories Technical Product Information at 1.800.962.8364.
About Roxane Laboratories, Inc.
Roxane Laboratories is located in
Roxane Laboratories, Inc., is a subsidiary of Boehringer Ingelheim Corporation, based in
About Boehringer Ingelheim
Boehringer Ingelheim Corporation based in
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim,
In 2007, Boehringer Ingelheim posted net sales of US
For more information on Boehringer Ingelheim, please visit
(1) IMS MAT dollar sales ending 12/2008
CellCept(R) is a registered trademark of Hoffmann – La Roche, Inc.
SOURCE Roxane Laboratories, Inc.